Tesamorelin 2mg Research Peptide
A stabilized synthetic analog of growth-hormone-releasing hormone studied within endocrine and metabolic research.
View Certificate of AnalysisFor Research Use Only (RUO) · Not for human or veterinary use · Delivery in 4–5 business days
A stabilized GHRH analog for endocrine research.
Tesamorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH), modified with an added chemical group at its N-terminus that protects the molecule from enzymatic breakdown and extends its research half-life relative to native GHRH.
Because it acts on the GHRH receptor at the level of the pituitary, Tesamorelin is studied for its role in the physiological release of growth hormone and its downstream metabolic signaling, particularly in models examining adipose-tissue distribution.
CellTheory supplies Tesamorelin as a lyophilized research peptide with HPLC-verified purity, mass-spectrometry identity confirmation, and a batch-specific Certificate of Analysis.
Research Applications
GHRH Signaling
Studied for pituitary GHRH-receptor engagement in research models.
Metabolic Distribution
Investigated within adipose-tissue and metabolic literature.
Peptide Stabilization
Illustrates N-terminal modification for extended half-life.
Independently Tested.
Verified by Batch.
Batch CT24-TES-012
Questions.
Tesamorelin is supplied as a lyophilized (freeze-dried) research compound in a sealed glass vial containing 2mg. It is intended strictly for in-vitro laboratory research and is not for human or veterinary use.